CannonW. B.McIverM. A.BlissS. W. (1924), Am. J. Physiol., 69, 46.
2.
CopeO.MarksH. P. (1934), J. Physiol., 83, 157.
3.
De WesselowO. L. V.GriffithsW. J. (1938), Quart. J. Med., 7, 17.
4.
De WesselowO. L. V.GriffithsW. J. (1936), Lancet (i), 991.
5.
FlaumG. (1938), Endocrinology, 23, 630.
6.
GrollmannA. (1936), “The Adrenals”. London, p. 131.
7.
HallG. E. (1938), Am. f. Psychiat., 95, 553.
8.
HimsworthH. P. (1936), Lancet (i), 127.
9.
JonesM. S. (1936), J. Ment. Sc., 82, 785.
10.
LawrenceR. D. (1928), Quart. f. Med., 21, 359.
11.
RogoffJ. M.MarcusE. (1938), J.A.M.A., 110, 2127.
12.
RootH. H. (1929), New England J. Med., 201, 201.
13.
ShawF. H. (1938), Biochem. J., 32, 19.
14.
StewartG. N.RogoffJ. M. (1916), J. Pharmacol. & Exper. Therap., 8, 479.
15.
WhitehornJ. C. (1934), J. Biol. Chem., 108, 633.
16.
YoungF. G. (1936a), Lancet (ii), 237 and 297.
17.
YoungF. G. (1936b), J. Physiol., 87, 13P.
18.
CannonW. B.McIverM. A.BlissS. W. (1924), Am. J. Physiol., 69, 46.
19.
CopeO.MarksH. P. (1934), J. Physiol., 83, 157.
20.
De WesselowO. L. V.GriffithsW. J. (1938), Quart. J. Med., 7, 17.
21.
De WesselowO. L. V.GriffithsW. J. (1936), Lancet (i), 991.
22.
FlaumG. (1938), Endocrinology, 23, 630.
23.
GrollmannA. (1936), “The Adrenals”. London, p. 131.
24.
HallG. E. (1938), Am. f. Psychiat., 95, 553.
25.
HimsworthH. P. (1936), Lancet (i), 127.
26.
JonesM. S. (1936), J. Ment. Sc., 82, 785.
27.
LawrenceR. D. (1928), Quart. f. Med., 21, 359.
28.
RogoffJ. M.MarcusE. (1938), J.A.M.A., 110, 2127.
29.
RootH. H. (1929), New England J. Med., 201, 201.
30.
ShawF. H. (1938), Biochem. J., 32, 19.
31.
StewartG. N.RogoffJ. M. (1916), J. Pharmacol. & Exper. Therap., 8, 479.
32.
WhitehornJ. C. (1934), J. Biol. Chem., 108, 633.
33.
YoungF. G. (1936a), Lancet (ii), 237 and 297.
34.
YoungF. G. (1936b), J. Physiol., 87, 13P.
35.
KochW.MannS. A., A chemical study of the brain in healthy and diseased conditions, with especial reference to dementia præcox, Arch. Neurol. & Psychiat., 1909, 4, 174–219.
36.
HaldaneJ. S., The symptoms, causes and prevention of anoxæmia, Brit. M. J., 1919 (ii), 65.
37.
LoevenhartA. S.LorenzW. F.WatersR. M., Cerebral Stimulation, J.A.M.A., 1929, 13, 880–883.
38.
HinsieL. E.BarachA. L.HarrisM. M.BrandE.McFarlandA., Treatment by continuous oxygen administration and oxygen and carbon dioxide inhalations, Psychiatric Quart., 1934, 8, 34.
39.
HadfieldG.GarrodL. P., “Recent Advances in Pathology”. Churchill, 1932.
40.
FreemanW., Deficiency of catalytic iron in the brain in schizophrenia. “Assocn. for Research in Nervous and Mental Disease”, Vol. X. Baltimore.
41.
GollaF. P.MannS. A.MarchH., The respiratory regulation in psychotic subjects, J. Ment. Sc., 1928, 74, 443.
42.
GoodallE., Physical research in psychiatry, Proc. Roy. Soc. Med., 13, Part I, 49.
43.
EwenJ. H., J. Neurol. & Psychopath., Jan. 1934, 55, 247–281.